We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page.
Lipid Manager (formerly the LDL-C Manager) helps clinicians reduce ASCVD risk by managing patients' LDL-C and triglycerides. The app guides clinicians through one continuous lipid-lowering process by linking four tools – the ASCVD Risk Estimator, LDL-C Lowering Therapies app, Statin Intolerance app, and the Hypertriglyceridemia app – all based on up-to-date ACC clinical policy.
Input individualized patient data to:
- Estimate ASCVD risk
- Review customized lifestyle and statin initiation advice
- Assess patient-specific response to lipid-lowering therapy
- Determine when and which non-statin therapies should be considered
- Recommend lifestyle intervention and pharmacological management of high-risk patients with persistent hypertriglyceridemia
Email yourself a detailed report of all assessments conducted within the app.
Advice from the app is derived from official ACC clinical policy documents including the 2013 ACC/AHA Guidelines on the Assessment of Cardiovascular Risk, the 2018 ACC/AHA et al. Guideline on the Management of Blood Cholesterol, the 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients with Persistent Hypertriglyceridemia, and the 2022 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk.
The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
This was developed as part of the ACC's Lipid Management Solutions Initiative. Financial support for the Initiative was provided by Amgen Inc and Regeneron. All of the content was independently developed with no sponsor involvement.